Wang, B.-D., Ceniccola, K., Hwang, S., Andrawis, R., Horvath, A., Freedman, J. A., … Lee, N. H. (2017). Corrigendum: Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Nat Commun, 8, 16161. https://doi.org/10.1038/ncomms16161

Wang, Bi-Dar, Kristin Ceniccola, SuJin Hwang, Ramez Andrawis, Anelia Horvath, Jennifer A. Freedman, Jacqueline Olender, et al. “Corrigendum: Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer.” Nat Commun 8 (September 27, 2017): 16161. https://doi.org/10.1038/ncomms16161.

Wang B-D, Ceniccola K, Hwang S, Andrawis R, Horvath A, Freedman JA, et al. Corrigendum: Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Nat Commun. 2017 Sep 27;8:16161.

Wang, Bi-Dar, et al. “Corrigendum: Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer.” Nat Commun, vol. 8, Sept. 2017, p. 16161. Pubmed, doi:10.1038/ncomms16161.

Wang B-D, Ceniccola K, Hwang S, Andrawis R, Horvath A, Freedman JA, Olender J, Knapp S, Ching T, Garmire L, Patel V, Garcia-Blanco MA, Patierno SR, Lee NH. Corrigendum: Alternative splicing promotes tumour aggressiveness and drug resistance in African American prostate cancer. Nat Commun. 2017 Sep 27;8:16161.